Validation of a Screening Scale for Misuse of Opioid Analgesics

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-02-23

Study Completion Date

2025-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In oncology, pain is one of the main symptoms of discomfort. It has a significant impact on the quality of life.The use of opioid analgesics is recommended for the treatment of moderate to severe cancer pain.The misuse of opioid analgesics is an international public health problem.Different scales have been developed to help the prescriber screen for the risk of misuse in the general population. Patients with cancer-related pain are also at risk for aberrant opioid-related behaviors, misuse or addiction.

The main objectif of this study is to validate of the screening scale for the misuse of opioid analgesics in patients with chronic pain related to cancer. (Prescription Opioid Misuse Index - POMI).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cross-cultural Validation of a Screening Scale for the Misuse of Opioid Analgesics in Primary Care

NCT05431985

Chronic Pain Addiction Opiate

COMPLETED

Opioid Misuse in Patients with Cancer

NCT06489769

Cancer Opioid Use Opioid Misuse +2 more

RECRUITING

Primary Dependence to Analgesic Drugs

NCT03684317

Addiction

UNKNOWN

Opioid Rotation Versus Combination for Chronic Uncontrolled Cancer Pain

NCT00478101

Advanced Solid Cancers

COMPLETED PHASE2

Self Reported Deviations From Opioid Analgesic Prescription

NCT00907192

Advanced Cancers

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study takes place in 2 phases.

Test phase :

Questionnaire no. 1 constitutes the data for the TEST phase: it includes socio-demographic data, medical and family history, lifestyle, treatments, 5 questions from the Concise Pain Questionnaire (QCD), the French version of the POMI scale, the diagnostic criteria of the DSM-V and two questions concerning anxiety associated with pain and therapeutic education.

Retest phase :

questionnaire no. 2 10 to 15 days later.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Pain Opioid Analgesic Adverse Reaction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

cancer patients

Questionnaires

Intervention Type OTHER

questionnaire including socio-demographic data, medical and family history, lifestyle, treatments, 5 questions from the Questionnaire Concis sur les Douleurs (QCD), the French version of the POMI scale, the diagnostic criteria of the DSM-V and two questions concerning anxiety associated with pain and therapeutic education.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaires

questionnaire including socio-demographic data, medical and family history, lifestyle, treatments, 5 questions from the Questionnaire Concis sur les Douleurs (QCD), the French version of the POMI scale, the diagnostic criteria of the DSM-V and two questions concerning anxiety associated with pain and therapeutic education.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged 18 and over,
* Patients with chronic cancer-related pain that has been evolving for at least 3 months,
* Patients with a regular prescription of at least one opioid analgesic medicine taken daily for at least 1 month,
* Patients followed in oncology for an active cancerous pathology.

Exclusion Criteria

* Stopping opioid prescriptions on the day of the test phase (no Retest possible),
* Patients in the process of weaning (risk of being weaned during the Retest phase),
* Patients unable to complete the questionnaire on their own,
* Patients followed in a pain or addiction centre,
* Patients in terminal palliative situations of their cancer,
* Patients with chronic pain that is more disabling than cancer-related pain,
* Patients refusing to participate,
* Patients under guardianship or curatorship,
* Pregnant or breastfeeding patients,
* Patient with a language barrier limiting understanding of the questionnaire in French.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No